Cardio Center, Humanitas Research Hospital IRCCS, Rozzano-Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.
Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Am J Cardiol. 2023 Oct 1;204:268-275. doi: 10.1016/j.amjcard.2023.07.114. Epub 2023 Aug 9.
In patients with advanced heart failure (HF), defined according to the presence of at least one I-NEED-HELP criterium, the updated 2018 Heart Failure Association of the European Society of Cardiology (HFA-ESC) criteria for advanced HF identify a subgroup of patients with HF with worse prognosis, but whether ischemic etiology has a relevant prognostic impact in this very high-risk cohort is unknown. Patients from the HELP-HF registry were stratified according to ischemic etiology and presence of advanced HF based on 2018 HFA-ESC criteria. The primary end point was a composite of all-cause death and HF hospitalization at 1 year. Secondary end points were all-cause death, HF hospitalization, and cardiovascular death at 1 year. Ischemic etiology was a leading cause of HF, in both patients with advanced and nonadvanced HF (46.1% and 42.4%, respectively, p = 0.337). The risk of the primary end point (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.09 to 1.58) and all-cause mortality (HR 1.37, 95% CI 1.06 to 1.76) was increased in ischemic as compared with nonischemic patients. The risk of the primary end point was consistently higher in ischemic patients in both patients with advanced and nonadvanced HF (advanced HF, HR 1.50 95% CI 1.04 to 2.16; nonadvanced HF, HR 1.25 95% CI 1.01 to 1.56, p = 0.333), driven by an increased risk of mortality, mainly because of cardiovascular causes. In conclusion, ischemic etiology is the most common cause of HF in patients with at least one I-NEED-HELP marker and with or without advanced HF as defined by the 2018 HFA-ESC definition. In both patients with advanced and not-advanced HF, ischemic etiology carried an increased risk of worse prognosis.
在至少有一个 I-NEED-HELP 标准的晚期心力衰竭(HF)患者中,根据 2018 年欧洲心脏病学会心力衰竭协会(HFA-ESC)的更新标准,晚期 HF 确定了一组预后更差的 HF 患者,但缺血性病因在这一极高风险患者群体中是否具有相关的预后影响尚不清楚。根据 2018 年 HFA-ESC 标准,将 HELP-HF 登记处的患者分为缺血性病因和存在晚期 HF 亚组。主要终点是 1 年时全因死亡和 HF 住院的复合终点。次要终点是 1 年时的全因死亡、HF 住院和心血管死亡。在晚期和非晚期 HF 患者中,缺血性病因都是 HF 的主要病因(分别为 46.1%和 42.4%,p=0.337)。与非缺血性患者相比,缺血性患者的主要终点(风险比[HR]1.31,95%置信区间[CI]1.09 至 1.58)和全因死亡率(HR 1.37,95%CI 1.06 至 1.76)的风险增加。在晚期和非晚期 HF 患者中,缺血性患者的主要终点风险始终更高(晚期 HF,HR 1.50 95%CI 1.04 至 2.16;非晚期 HF,HR 1.25 95%CI 1.01 至 1.56,p=0.333),这主要是由于心血管原因导致死亡率增加所致。总之,在至少有一个 I-NEED-HELP 标志物的患者中,缺血性病因是 HF 的最常见原因,无论 2018 年 HFA-ESC 标准定义的 HF 是否为晚期。在晚期和非晚期 HF 患者中,缺血性病因均预示着预后更差。